Overview

Selective Digestive Decontamination in Carriers of Carbapenem-resistant Klebsiella Pneumoniae

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
0
Participant gender:
All
Summary
There is an urgent need to control our current national outbreak of carbapenem-resistant Klebsiella pneumoniae (CRKP). The purpose of this study is to eradicate CRKP gastrointestinal carriage using selective digestive decontamination (SDD); with buccal and oral gentamicin and polymyxin E administration. This will reduce infections and hopefully mortality caused by CRKP.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Soroka University Medical Center
Treatments:
Colistin
Gentamicins
Pharmaceutical Solutions
Polymyxins
Criteria
Inclusion Criteria:

- Hospitalized men and women with a positive rectal swab for CRKP

- Age 18 years or older

Exclusion Criteria:

- Age less than 18 years

- Pregnant women, lactating women

- A known allergy to the study drugs